Literature DB >> 3710729

Pathogenesis of Chandler's syndrome, essential iris atrophy and the Cogan-Reese syndrome. II. Estimated age at disease onset.

J A Alvarado, C G Murphy, R P Juster, J Hetherington.   

Abstract

The presence of a layer of abnormal material in Descemet's membrane in eight keratoplasty specimens served as a marker to determine whether Chandler's syndrome, Essential Iris Atrophy, and the Cogan-Reese syndrome are congenital or acquired conditions. In all eight cases of the ICE syndrome, a pattern of membrane deposition was observed, which typifies acquired disorders: a completely normal prenatal layer and both normal and abnormal portions of the postnatal layer. The thickness of the membrane deposited before the onset of abnormal secretion was used to estimate a time span for possible ages at which abnormal secretion began. The estimated age intervals for all diseased specimens had their lower limits in the postnatal period. Thus, these results led us to the conclusion that abnormal Descemet's membrane first appeared in postnatal life, years before clinical recognition of disease. The possibility of a viral etiology for this unilateral endotheliopathy resulting in an altered Descemet's membrane is discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3710729

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Pathogenesis of the ICE syndrome.

Authors:  R J Buckley
Journal:  Br J Ophthalmol       Date:  1994-08       Impact factor: 4.638

2.  Corneal endothelial cell abnormalities in an early stage of the iridocorneal endothelial syndrome.

Authors:  W R Lee; G E Marshall; C M Kirkness
Journal:  Br J Ophthalmol       Date:  1994-08       Impact factor: 4.638

3.  A clinicopathologic study of posterior polymorphous dystrophy:implications for pathogenetic mechanism of the associated glaucoma.

Authors:  A B Threlkeld; W R Green; H A Quigley; Z de la Cruz; W J Stark
Journal:  Trans Am Ophthalmol Soc       Date:  1994

4.  Distinguishing features of the iridocorneal endothelial syndrome and posterior polymorphous dystrophy: value of endothelial specular microscopy.

Authors:  H C Laganowski; E S Sherrard; M G Muir; R J Buckley
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

5.  In-vivo confocal microscopy of iridocorneal endothelial syndrome.

Authors:  Qi-Hua Le; Xing-Huai Sun; Jian-Jiang Xu
Journal:  Int Ophthalmol       Date:  2008-02-23       Impact factor: 2.031

6.  Progression and regression of partial corneal involvement in the iridocorneal endothelial syndrome.

Authors:  W M Bourne; R F Brubaker
Journal:  Trans Am Ophthalmol Soc       Date:  1992

7.  Iridocorneal endothelial syndrome: Evaluation of patient demographics and endothelial morphology by in vivo confocal microscopy in an Indian cohort.

Authors:  Chintan Malhotra; Natasha G Seth; Surinder S Pandav; Arun K Jain; Sushmita Kaushik; Amit Gupta; Srishti Raj; Deepika Dhingra
Journal:  Indian J Ophthalmol       Date:  2019-05       Impact factor: 1.848

8.  Iridocorneal Endothelial Syndrome: Case Report of Essential Progressive Iris Atrophy.

Authors:  Allen Popovic Beganovic; Amra Nadarevic Vodencarevic; Meliha Halilbasic; Anis Medjedovic
Journal:  Med Arch       Date:  2022-06

9.  Metagenomic Deep Sequencing to Investigate for an Infectious Etiology of Iridocorneal Endothelial Syndrome.

Authors:  Plern Sutra; Jennifer Rose-Nussbaumer; John A Gonzales; Kaidi Wang; Armin Hinterwirth; Gerami Seitzman; Michele Bloomer; Nisha Acharya; Thuy Doan
Journal:  Cornea       Date:  2020-10       Impact factor: 3.152

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.